Brolucizumab Use in Treatment Resistant Neovascular Age Related Macular Degeneration (nAMD)

被引：0
|
作者：
Shortell, Justin [1 ]
Hill, Christine [2 ]
Thomas, Claire [3 ]
Peck, Travis [1 ]
Melamud, Alexander [1 ]
机构：
[1] MedStar Georgetown Univ Hosp, Ophthalmol, Washington, DC USA
[2] Med Univ South Carolina, Ophthalmol, Charleston, SC USA
[3] Univ Virginia, Charlottesville, VA USA
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2023年 / 64卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Reference Standards for Assessment of Fluid in Neovascular Age-Related Macular Degeneration (nAMD)
    Malik, Kunal
    Lanser, Melissa
    Pak, Jeong
    Banghart, Mark
    Blodi, Barbara
    Domalpally, Amitha
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2021, 62 (08)
  • [22] Brolucizumab and fluid in neovascular age-related macular degeneration (n-AMD)
    Ashish Sharma
    Nilesh Kumar
    Nikulaa Parachuri
    Rohini Sharma
    Francesco Bandello
    Baruch D. Kuppermann
    Carl D. Regillo
    Eye, 2020, 34 : 1310 - 1312
  • [23] NEOVASCULAR AGE-RELATED MACULAR DEGENERATION (NAMD) IN ITALY: A SOCIAL COST ANALYSIS
    Fasci, A.
    Pradelli, L.
    VALUE IN HEALTH, 2022, 25 (12) : S261 - S261
  • [24] Efficacy of switching to brolucizumab for neovascular age-related macular degeneration refractory to faricimab
    Hoshino, Junki
    Matsumoto, Hidetaka
    Nakamura, Kosuke
    Akiyama, Hideo
    JAPANESE JOURNAL OF OPHTHALMOLOGY, 2025, : 221 - 229
  • [25] Brolucizumab and fluid in neovascular age-related macular degeneration (n-AMD)
    Sharma, Ashish
    Kumar, Nilesh
    Parachuri, Nikulaa
    Sharma, Rohini
    Bandello, Francesco
    Kuppermann, Baruch D.
    Regillo, Carl D.
    EYE, 2020, 34 (08) : 1310 - 1312
  • [26] Bevacizumab for the treatment of neovascular age related macular degeneration
    Chakravarthy, Usha
    BMJ-BRITISH MEDICAL JOURNAL, 2010, 340
  • [27] Generation of a Lentiviral Based Gene Therapy Vector for the Treatment of Neovascular Age-Related Macular Degeneration (nAMD)
    Iqball, Sharifah
    Guzman, Efrain
    Kelleher, Michelle
    Beck, Daniel
    Devarajan, Gayathri
    Khoo, Cheen
    O'Connor, Deirdre
    Harrop, Richard
    Mitrophanous, Kyriacos A.
    Lad, Yatish
    MOLECULAR THERAPY, 2021, 29 (04) : 265 - 265
  • [28] A CONSENSUS ON RISK MITIGATION FOR BROLUCIZUMAB IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION Patient Selection, Evaluation, and Treatment
    Holz, Frank G.
    Iida, Tomohiro
    Maruko, Ichiro
    Sadda, Srinivas R.
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2022, 42 (09): : 1629 - 1637
  • [29] Brolucizumab: A Newly Developed Anti-VEGF Molecule for the Treatment of Neovascular Age-Related Macular Degeneration
    Tadayoni, Ramin
    Sararols, Laura
    Weissgerber, Georges
    Verma, Rohini
    Clemens, Andreas
    Holz, Frank G.
    OPHTHALMOLOGICA, 2021, 244 (02) : 93 - 101
  • [30] Intravitreal Aflibercept for Treatment-Resistant Neovascular Age-related Macular Degeneration
    Chang, Andrew A.
    Li, Haitao
    Broadhead, Geoffrey K.
    Hong, Thomas
    Schlub, Timothy E.
    Wijeyakumar, Wijeyanthy
    Zhu, Meidong
    OPHTHALMOLOGY, 2014, 121 (01) : 188 - 192
12345